Theodorus Flipsen
Chief Executive Officer at PolyVation BV
Network origin in Theodorus Flipsen first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
InGell Labs BV
 InGell Labs BV Pharmaceuticals: MajorHealth Technology InGell Labs BV develops polymer-based injectable hydrogels for drug delivery. The firm’s products include InGell LQP, Ingell Gamma, and running in-house projects. It offers its bioabsorbable injectable hydrogel systems for reducing side-effects and localization of novel therapies to life-cycle management opportunities. The company was founded by Paul van Midwoud, Theodorus Adrianus Cornelius Flipsen, Mike G. de Leeuw, and Jan P. M. Hendriks in 2010 and is headquartered in Groningen, the Netherlands.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
InnoCore Technologies BV
 InnoCore Technologies BV Pharmaceuticals: MajorHealth Technology InnoCore Technologies BV develops drug delivery technologies. It serves the pharmaceutical and medical device industry by developing and manufacturing innovative drug delivery systems that enhance their products. The company was founded by Theodorus Adrianus Cornelius Flipsen and Rob Steendam in 2004 and is headquartered in Groningen, the Netherlands.
3
| Holding Company | Pharmaceuticals: Major | 3 |
PolyVation BV
 PolyVation BV Miscellaneous Commercial ServicesCommercial Services PolyVation BV provides research, development, custom synthesis, and manufacturing services relating to polymers for biomedical and pharmaceutical applications. The firm performs biocompatibility research such as review, planning, rationales, physico-chemical, and biological tests. It also offers vinyl pyrolidone, acrylate, and silicone. The company was founded by Theodorus Adrianus Cornelius Flipsen in 1996 and is headquartered in Groningen, the Netherlands.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Theodorus Flipsen via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of Groningen | College/University | Doctorate Degree Doctorate Degree | |
Pharma Connect Capital
 Pharma Connect Capital Investment ManagersFinance Pharma Connect Capital BV is a private equity firm with headquarters in Groningen, the Netherlands. It was founded in 2017. | Investment Managers | Private Equity Investor | |
Blue Medical Devices BV
 Blue Medical Devices BV Medical SpecialtiesHealth Technology Part of Translumina Therapeutics LLP, Blue Medical Devices BV is a Dutch company that manufactures cardiovascular devices. The company is based in Helmond, Netherlands. The company was founded by Ronald A.M. Horvers. Noel Coopmans has been the CEO of the company since 2012. Blue Medical Devices was acquired by Translumina GmbH from Wellinq Holding BV on June 29, 2023. | Medical Specialties | Corporate Officer/Principal | |
| Occam International BV | Corporate Officer/Principal | ||
Merit Medical Coatings BV
 Merit Medical Coatings BV Industrial SpecialtiesProcess Industries Part of Merit Medical Systems, Inc., Merit Medical Coatings BV is a Dutch company that develops coating of wire and polymers for medical applications. The company is based in Venlo, the Netherlands. Merit Medical Coatings was acquired by Merit Medical Systems, Inc. from Angiotech Pharmaceuticals, Inc. on January 03, 2006 for $3 million. | Industrial Specialties | Corporate Officer/Principal | |
Polyganics BV
 Polyganics BV Medical SpecialtiesHealth Technology Polyganics BV engages in the development, manufacture, and commercialization of bioresorbable medical devices that facilitate tissue repair and regeneration. It offers pipeline, peripheral nerve repair, neurosurgery, and general surgery products . The company was founded in 1999 and is headquartered in Groningen, the Netherlands. | Medical Specialties | Corporate Officer/Principal | |
Organon NV
 Organon NV Pharmaceuticals: MajorHealth Technology N.V. Organon engages in the development, manufacture, and sale of prescription medicines. It offers products for cardiovascular diseases, fertility, gynecology, anesthesia, respiratory, consumer health care, neuroscience as well as immunology, animal health, and oncology. Its products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. The company was founded in 1923 and is headquartered in Oss, the Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Gist-Brocades International BV | Corporate Officer/Principal | ||
Dr. Reddy's Research & Development BV
 Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistics
International
| Netherlands | 11 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 2 |
| Commercial Services | 2 |
| Finance | 2 |
| Process Industries | 2 |
Operational
| Corporate Officer/Principal | 11 |
| Founder | 4 |
| Chief Executive Officer | 2 |
| Doctorate Degree | 2 |
| Graduate Degree | 2 |
Most connected contacts
- Stock Market
- Insiders
- Theodorus Flipsen
- Company connections
